We have previously identified a point mutation (intervening sequence (IVS) 4: T 3 C) in the branchpoint consensus sequence of intron 4 of the lecithin:cholesterol acyltransferase (LCAT) gene in patients with fisheye disease. To investigate the possible mechanisms responsible for the defective splicing, we made a series of mutations in the branchpoint sequence and expressed these mutants in HEK-293 cells followed by the analysis of pre-mRNA splicing using reverse transcriptase-polymerase chain reaction as well as LCAT activity assay. The results reveal that 1) the mutation of the branchpoint adenosine to any other nucleotide completely abolishes splicing; 2) the insertion of a normal branch site into the intronic sequence of the natural (IVS4-22c) or the branchpoint (IVS4-20t) mutant completely restores splicing; 3) the natural mutation can be partially rescued by making a single nucleotide change (G 3 A) within the branchpoint consensus sequence; and 4) other single base changes, particularly around the branchpoint adenosine residue, significantly decrease the efficiency of splicing and thus enzyme activity. Surprisingly, the nucleotide transversion at the last position of the branchpoint sequence (i.e. IVS4-25a or -25g) results in a 2.7-fold increase in splicing efficiency. Therefore, these observations clearly establish the functional significance of the branchpoint sequence of intron 4 for the splicing of the human LCAT mRNA precursors.The removal of introns from pre-mRNA involves the recognition of the 5Ј-splice site, the branchpoint sequence, and the 3Ј-splice site by five small nuclear ribonucleoprotein particles (snRNPs), i.e. U1, U2, U5, and U4/U6, and a large number of non-snRNP splicing factors (1-4). The functional significance of the splice sites has been well established by the studies of a number of naturally occurring mutations and of site-directed mutagenesis at these exon/intron junctions (5-8). It is estimated that up to 15% of all point mutations causing human genetic disease result from mRNA splicing defects, most of which involve a single nucleotide substitution at the splice sites (5). To date, only a few mutations in the branchpoint consensus sequence of introns have been reported to cause human genetic diseases (9 -13). However, the growing evidence indicates that the branchpoint sequence can be of essential importance for accurate and efficient splicing of human nuclear pre-mRNA.A series of elegant genetic experiments in both yeast and mammalian cell lines have shown that base pairs exist between the branchpoint sequence and a conserved region (5Ј-AU-GAUG-3Ј) in U2 snRNA (14 -16). The branchpoint sequence is absolutely conserved in yeast (UACUAAC; the underlined A indicates the branchpoint nucleotide). Mutations of the yeast branchpoint adenosine significantly reduce or abolish splicing (17). By contrast, the branchpoint sequence exhibits only a weak consensus in mammals (YNYURAY; where Y ϭ pyrimidine, R ϭ purine, and N ϭ any nucleotide), and mutations of the branchpoint adenine in mamma...